October 7, 2023 Comments Off on New patent expiration for Celgene drug REVLIMID Posted in: Uncategorized
Annual Drug Patent Expirations for REVLIMID Revlimid is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are fifteen patents protecting…
The post New patent expiration for Celgene drug REVLIMID appeared fi…
October 7, 2023 Comments Off on New patent for Viiv Hlthcare drug JULUCA Posted in: Patent Added Annual Drug Patent Expirations for JULUCA Juluca is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent for Viiv Hlthcare drug JULUCA appeared first on DrugPatentWa…
